http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0761672-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4acae202b6a15394281949545e70d2f6 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-587 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C239-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-24 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C239-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546 |
| filingDate | 1996-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33a3508a6e889c2af0632aa020c97806 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67dbd0bc07319f82be0658e1809b6845 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3881d872fe89d71b3a98c6872206e18 |
| publicationDate | 1997-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0761672-A1 |
| titleOfInvention | Cephalosporin containing in position 7 a substituted benzyloxyimino radical, processes for their preparation and intermediates for their preparation, their use as medicaments |
| abstract | The subject of the invention is the products of formula (I): syn isomer, in the form of internal salts or salts of acids or bases, in which: R 1 , R 2 , R 3 and R 5 , represent a hydrogen atom, halogen or a hydroxy radical, alkyl optionally substituted by halogen, alkyloxy, mercapto, alkylthio, nitro, cyano, amino, alkylamino, dialkylamino, carbamoyl , (alkylamino) carbonyl, (dialkylamino) carbonyl, carboxy, alkoxycarbonyl, acyloxy and where Rx and Ry represent hydrogen or alkyl, R 4 represents hydroxy or acyloxy, R 7 represents hydrogen or alkyloxycarbonyl, A represents hydrogen, an alkali, alkaline earth metal, magnesium, ammonium or an amino organic base, or the rest of an ester group, or else CO 2 A represents CO 2 ⊖ , CH 2 R 6 is in position E or Z and R 6 represents a quaternary ammonium, cyclic or non-cyclic.n n n These products have interesting pharmacological properties which justify their use as medicines. |
| priorityDate | 1995-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 453.